» Articles » PMID: 22412949

Different Infective Forms Trigger Distinct Immune Response in Experimental Chagas Disease

Abstract

Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host interaction and/or target cell invasion, they differ in the molecules present on the surface. Thus, aspects related to the variability that the forms of T. cruzi interacts with host cells may lead to fundamental implications on the immune response against this parasite and, consequently, the clinical evolution of Chagas disease. We have shown that BT infected mice presented higher levels of parasitemia during all the acute phase of infection. Moreover, the infection with either MT or BT forms resulted in increased levels of total leukocytes, monocytes and lymphocytes, specifically later for MT and earlier for BT. The infection with BT forms presented earlier production of proinflammatory cytokine TNF-α and later of IFN-γ by both T cells subpopulations. This event was accompanied by an early cardiac inflammation with an exacerbation of this process at the end of the acute phase. On the other hand, infection with MT forms result in an early production of IFN-γ, with subsequent control in the production of this cytokine by IL-10, which provided to these animals an immunomodulatory profile in the end of the acute phase. These results are in agreement with what was found for cardiac inflammation where animals infected with MT forms showed intense cardiac inflammation later at infection, with a decrease in the same at the end of this phase. In summary, our findings emphasize the importance of taking into account the inoculums source of T. cruzi, since vectorial or transfusional routes of T. cruzi infection may trigger distinct parasite-host interactions during the acute phase that may influence relevant biological aspects of chronic Chagas disease.

Citing Articles

New features on the survival of human-infective Trypanosoma rangeli in a murine model: Parasite accumulation is observed in lymphoid organs.

Ferreira L, de Araujo F, Martinelli P, Teixeira-Carvalho A, Alves-Silva J, Guarneri A PLoS Negl Trop Dis. 2020; 14(12):e0009015.

PMID: 33370305 PMC: 7793305. DOI: 10.1371/journal.pntd.0009015.


Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.

de Jesus S, Pinto L, Moreira F, Nardotto G, Cristofoletti R, Perin L Antimicrob Agents Chemother. 2020; 65(2).

PMID: 33168611 PMC: 7848981. DOI: 10.1128/AAC.01383-20.


Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.

Reis L, Brito R, Cardoso J, Mathias F, Aguiar Soares R, Carneiro C Antimicrob Agents Chemother. 2017; 61(11).

PMID: 28827416 PMC: 5655062. DOI: 10.1128/AAC.00962-17.


Host-Parasite Interactions in Chagas Disease: Genetically Unidentical Isolates of a Single Trypanosoma cruzi Strain Identified In Vitro via LSSP-PCR.

Nogueira-Paiva N, Vieira P, Oliveri L, Fonseca K, Pound-Lana G, Oliveira M PLoS One. 2015; 10(9):e0137788.

PMID: 26359864 PMC: 4567304. DOI: 10.1371/journal.pone.0137788.


The TcI and TcII Trypanosoma cruzi experimental infections induce distinct immune responses and cardiac fibrosis in dogs.

Duz A, Vieira P, Roatt B, Aguiar-Soares R, Cardoso J, de Oliveira F Mem Inst Oswaldo Cruz. 2015; 109(8):1005-13.

PMID: 25591108 PMC: 4325618. DOI: 10.1590/0074-02760140208.


References
1.
Rowland E . Bone marrow eosinophil levels in Trypanosoma cruzi infected mice. J Parasitol. 1984; 70(5):819-20. View

2.
Starobinas N, Russo M, Minoprio P, Hontebeyrie-Joskowicz M . Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice?. Res Immunol. 1991; 142(2):117-22. DOI: 10.1016/0923-2494(91)90019-f. View

3.
Gomes J, Bahia-Oliveira L, Rocha M, Martins-Filho O, Gazzinelli G, Correa-Oliveira R . Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun. 2003; 71(3):1185-93. PMC: 148818. DOI: 10.1128/IAI.71.3.1185-1193.2003. View

4.
Camargo M, Andrade A, Almeida I, Travassos L, Gazzinelli R . Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages. J Immunol. 1998; 159(12):6131-9. View

5.
Ribeirao M, Pereira-Chioccola V, Renia L, Augusto Fragata Filho A, Schenkman S, Rodrigues M . Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol. 1999; 22(1):49-53. DOI: 10.1046/j.1365-3024.2000.00260.x. View